FDA — authorised 20 June 2000
- Application: BLA021148
- Marketing authorisation holder: NOVO NORDISK INC
- Local brand name: NORDITROPIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Human Growth Hormone in United States
FDA authorised Human Growth Hormone on 20 June 2000
Marketing authorisations
FDA
- Status: approved
Human Growth Hormone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Human Growth Hormone approved in United States?
Yes. FDA authorised it on 20 June 2000; FDA has authorised it.
Who is the marketing authorisation holder for Human Growth Hormone in United States?
NOVO NORDISK INC holds the US marketing authorisation.